<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "vinCRIStine inj VIAL">
<dose><value>2</value>
<value>0.6</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>vinCRIStine inj VIAL</value>
</drugname><strength><value>1 mg/mL</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>DAY 1 of 21. Administer dose diluted in 0.9% sodium chloride 50 mL over 10 minutes.</value>
<value>DAY 2 of 21. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes.</value>
</instruction><volume><value>1 mL</value>
<value>2 mL</value>
</volume><units><value>mg</value>
<value>mg/m2</value>
</units><additionalnotes><value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay 1 week. If Creatinine Clearance is greater than or equal to 50 mL/minute: Give as ordered. If Creatinine Clearance is less than 50 mL/minute: Contact physician.</value>
</additionalnotes><population><value>cyclophosphamide, DOXOrubicin, vinCRIStine (CAV). Small Cell Lung Cancer.</value>
<value>CISplatin/DOXOrubicin/vinCRIStine/cyclophosphamide. Thymoma</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3460</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>02143305</value>
<value>02183013</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>